Apogee Therapeutics, Inc.
APGE • NASDAQ
Apogee Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Thomas Henderson, with a market cap of $5.8B.
CEOMichael Thomas Henderson
Next Earnings
Upcoming earnings announcement for Apogee Therapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.13
Earnings History
Past 11 earnings reports for Apogee Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$1.03Est: -$1.04 | +1.0% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$1.11Est: -$1.15 | +3.5% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$1.13Est: -$1.03 | -9.7% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.95Est: -$1.19 | +20.2% | - | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$1.19Est: -$1.11 | -7.2% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.86Est: -$0.77 | -11.7% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.60Est: -$0.60 | 0.0% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.64Est: -$0.61 | -4.9% | - | — | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.32Est: -$0.49 | +34.7% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.51 | — | - | — | — |
| Aug 28, 2023 | Q2 2023 | -$3.78 | — | - | — | 10-Q |